Titlebook: Cancer Proteomics; From Bench to Bedsid Sayed S. Daoud Book 2008 Humana Press 2008 Bioinformatics.Cancer Research.Carcinom.Oncology.Proteom

arbiter

擴(kuò)大

nuclear-tests

Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapyions, prediction of clinical outcome and monitoring response to cancer treatments. The exciting move toward kinase-targeted therapy has brought new technical challenges in profiling protein kinase genes and proteins as surrogate clinical biomarkers, particularly in light of clinical data correlating

osteoclasts

Oncoproteomics for Personalized Management of Cancer individual. Numerous proteomic technologies are available, and selected ones relevant to development of personalized therapy are described. Cancer biomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics

NAVEN

Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumorse detailed analysis of a diverse set of proteins and their isoforms at the molecular level. These new, high-throughput, and comprehensive proteomic studies can be useful in advancing our understanding of disease processes and have wide potential for integration within clinical trials. Clinical trial

Euphonious

hauteur